All posts tagged lia gore

  • Dasatinib excels in worldwide phase II trial against pediatric CML

    Worldwide phase II clinical trial results presented at ASCO 2017 show the promise of the second-generation drug dasatinib against pediatric CML. Of 113 pediatric patients studied, 75 percent of patients who had previously failed or did not tolerate imatinib saw progression-free survival 48 months after starting treatment with dasatinib.

CSU Animal Cancer Center
Morgan Adams Foundation
Emily Brown and Jeanette, her mother.